John Sakys Net Worth

The estimated Net Worth of John Sakys is at least $3.3 Million dollars as of 1 September 2024. Mr. Sakys owns over 1,037 units of Mesa Laboratories stock worth over $1,494,625 and over the last 12 years he sold MLAB stock worth over $677,660. In addition, he makes $1,128,600 as Chief Financial Officer, Executive Vice President, Chief Accounting Officer, and Corporate Secretary at Mesa Laboratories.

Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!

Sign up

Already have an account? Sign in

Mr. Sakys MLAB stock SEC Form 4 insiders trading

John has made over 37 trades of the Mesa Laboratories stock since 2015, according to the Form 4 filled with the SEC. Most recently he exercised 1,037 units of MLAB stock worth $123,994 on 1 September 2024.

The largest trade he's ever made was exercising 4,628 units of Mesa Laboratories stock on 22 March 2023 worth over $487,791. On average, John trades about 862 units every 60 days since 2013. As of 1 September 2024 he still owns at least 12,500 units of Mesa Laboratories stock.

You can see the complete history of Mr. Sakys stock trades at the bottom of the page.

John Sakys biography

John V. Sakys serves as Chief Financial Officer, Executive Vice President, Chief Accounting Officer, Corporate Secretary of the Company. From 2009 through October 2012, Mr. Sakys held several positions with The Berry Company, LLC, and its predecessor company, Local Insight Regatta Holdings, Inc., most recently as its Vice President and Chief Accounting Officer. From 2001 to 2009, Mr. Sakys was the Vice President and Chief Financial Officer of Isonics Corporation, a NASDAQ listed company based in the Denver area. From September 2000 to April 2001, Mr. Sakys was Controller of AuraServ Communications. From July 1998 to September 2000, Mr. Sakys was Director of Financial Reporting for Media One, Inc. From December 1994 to July 1998, Mr. Sakys was an audit manager at Ernst and Young LLP. Mr. Sakys received his Bachelor of Arts degree in Business Economics with an emphasis in accounting from the University of California at Santa Barbara in 1990 and is a Certified Public Accountant.

What is the salary of John Sakys?

As the Chief Financial Officer, Executive Vice President, Chief Accounting Officer, and Corporate Secretary of Mesa Laboratories, the total compensation of John Sakys at Mesa Laboratories is $1,128,600. There are 1 executives at Mesa Laboratories getting paid more, with Gary Owens having the highest compensation of $3,485,970.

How old is John Sakys?

John Sakys is 51, he's been the Chief Financial Officer, Executive Vice President, Chief Accounting Officer, and Corporate Secretary of Mesa Laboratories since 2012. There are 11 older and 1 younger executives at Mesa Laboratories. The oldest executive at Mesa Laboratories, Inc. is David Kelly, 78, who is the Independent Director.

What's John Sakys's mailing address?

John's mailing address filed with the SEC is MESA LABORATORIES, INC., 12100 W. 6TH AVENUE, LAKEWOOD, CO, 80228.

Insiders trading at Mesa Laboratories

Over the last 21 years, insiders at Mesa Laboratories have traded over $50,273,983 worth of Mesa Laboratories stock and bought 209,660 units worth $5,099,819 . The most active insiders traders include Mark Christopher Capone, R Tony Tripeny, and John James Sullivan. On average, Mesa Laboratories executives and independent directors trade stock every 20 days with the average trade being worth of $430,930. The most recent stock trade was executed by Gary M Owens on 6 September 2024, trading 3,301 units of MLAB stock currently worth $394,701.

What does Mesa Laboratories do?

mesa laboratories, inc., develops, manufactures and markets high-quality process validation, monitoring and calibration instruments and consumables worldwide. mesa offers quality data loggers for monitoring temperature, humidity, and pressure and biological indicators (bis) for medical device and pharmaceutical manufacturing sterilization monitoring. the datatrace data loggers and mesa bis are available to monitor and validate applications including steam and eo sterilization, autoclave validation, incubators, heat tunnels and more. mesa’s bi offering also includes bis for industrial use, hydrogen peroxide (h2o2), chlorine dioxide and more. the phoenix meter is a point-of-use dialysate qc meter used prior to each procedure. the 90xl meter is the industry standard for calibration of dialysis machines in the field. also available are industry leading nist-traceable calibration solutions. mesa also offers cap torque testers which are durable, reliable and computerized cap torque analyzers

Complete history of Mr. Sakys stock trades at Mesa Laboratories

Mesa Laboratories executives and stock owners

Mesa Laboratories executives and other stock owners filed with the SEC include:

• Gary Owens,
  President, Chief Executive Officer, Director
• John Sakys,
  Chief Financial Officer, Executive Vice President, Chief Accounting Officer, Corporate Secretary
• Greg DiNoia,
  Senior Vice President - Commercial Operations
• Gary M. Owens,
  CEO, Pres & Director
• Brian Archbold,
  Senior Vice President - Continuous Improvement
• Brian David Archbold,
  Sr. VP of Continuous Improvement
• John V. Sakys,
  CFO & Chief Accounting Officer
• Gregory T. DiNoia,
  Sr. VP of Commercial Operations
• John Sullivan,
  Chairman of the Board
• John Schmieder,
  Independent Director
• David Kelly,
  Independent Director
• Evan Guillemin,
  Independent Director
• Jennifer Alltoft,
  Independent Director
• Shannon Hall,
  Director
• Peter M. Dansky,
  Pres of Clinical Genomics
• Garrett Krushefski,
  Sr. VP of Operations
• Bryan T. Leo,
  Sr. VP of Operations
• Gina Hinman Trulli,
  VP of HR
• Elizabeth Karpinski Vonne,
  VP of Legal, Gen. Counsel & Sec.
• Robert Bradley,
  Sr. Director of Operations
• Michael T Brooks,
  Director
• H Stuart Campbell,
  Director
• Ventures, Llc Seg,
  Director
• Luke R Schmieder,
  President CEO Treasurer
• Paul D Duke,
  Director
• Michael Tranmer,
  Executive Vice President
• Glenn E Adriance,
  VP Sales and Marketing
• Steven W Peterson,
  VP Finance, CFO, Secretary
• Robert V Dwyer,
  Director
• David Brian Perez,
  Director
• Mark Christopher Capone,
  Director
• Shiraz Shabanali Ladiwala,
  Director
• Laboratories Inc /Co/ Mesa,
  Director
• R Tony Tripeny,
  Director